Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-25 @ 3:46 AM
NCT ID:
NCT06171802
Eligibility Criteria:
Inclusion Criteria:
Severe symptomatic aortic stenosis AND Surgical or transcatheter aortic valve replacement within 14 days
Exclusion Criteria:
* Prior treatment with a SGLT2i
* Left ventricular ejection fraction \< 45%
* Estimated Glomerular Filtration Rate (eGFR) \< 30 mL/min
* Hypersensitivity to empagliflozin or placebo tablet
* Type I Diabetes
* Patients who do not understand Danish or English
* Women who are pregnant or are nursing or plan to become pregnant during trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06171802
Study Brief:
Protocol Section:
NCT06171802